The interwoven relationship connecting sleep health and cardiovascular wellness has garnered escalating attention within medical research. Of particular fascination is the intersection of two distinct elements: Obstructive Sleep Apnea (OSA) and Hypertension. Recent investigations have plunged into the repercussions of this dual combination on pivotal biomarkers – telomerase, visfatin and adipsin – alongside the well-being of the vascular system, as gauged through Flow-Mediated Dilation (FMD). This piece of writing delves into the elaborate interplay between OSA and HTA concerning these variables, accentuating the divergent vascular implications experienced by HTA patients with and without OSA. Obstructive Sleep Apnea manifests as irregular breathing patterns during slumber, ushering in periods of intermittent hypoxia and sleep disruption.
HTML PDFShare this article
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
